TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability--Hagens Berman

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Hagens Berman
Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability--Hagens Berman

Telix Pharmaceuticals faces a securities class action lawsuit alleging misleading statements about prostate cancer drug development and supply chain reliability, resulting in significant stock price declines after SEC subpoena and FDA rejection.

Insights
TLX   negative

Company faced a class action lawsuit, received an SEC subpoena, experienced a FDA Complete Response Letter rejection, and saw stock prices drop over 34% due to alleged misrepresentations about drug development and supply chain reliability